Aliri Bioanalysis Appoints John Moriarity as Senior Vice President, North American Bioanalytical Sales
September 29, 2025 – Aliri Bioanalysis, a leading provider of precision bioanalytical and spatial multi-omics solutions for drug developers, is pleased to announce the appointment of John Moriarity as Senior Vice President, North American Bioanalytical Sales. This strategic addition to Aliri’s leadership team underscores the company’s commitment to building a world-class team focused on delivering speed, quality, and innovation to its customers.
John brings more than 20 years of biopharma experience to Aliri, beginning his career as a bench chemist and progressing through roles of increasing responsibility, leading him to business development. His deep industry knowledge and proven leadership make him a valuable addition to Aliri’s executive team.
John is no stranger to Aliri, having previously worked at Tandem Labs, a legacy brand that helped shape the company’s foundation. He has also held key sales leadership roles at Covance, BioAgilytix, and most recently served as Vice President of Business Development at Prolytix.
John Moriarity shares:
“It’s an exciting time to join Aliri, as the company is poised to lead the next chapter of growth in our industry. I look forward to partnering closely with customers to help them gain a decisive edge, accelerate timelines, make insight-driven decisions, and bring forward the breakthroughs that matter most.”
This appointment reflects Aliri’s deep commitment to our People First and Science Strong values, while further strengthening our leadership team to deliver advanced solutions that empower drug developers with robust data to drive strategic decision-making.
Kevin Jones, President of Aliri Bioanalysis, comments:
“Pharma companies are moving faster than ever, and they need partners who can keep pace. John brings the vision, energy, and industry experience to ensure we rise to that challenge and deliver unmatched value for our clients.”
